Sepsis Clinical Trial
Official title:
A Prospective Observational Study of the Expectations and Physiological Effects of Fluid Bolus Therapy in the Intensive Care Unit
NCT number | NCT03178578 |
Other study ID # | LNR/17/Austin/94 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | May 18, 2017 |
Est. completion date | January 2020 |
This prospective observational study aims to (i) asses intensive care doctors trigger for and the expected physiological response to a fluid bolus and (ii) evaluate the patient's actual physiological response to a single fluid bolus at one hour post-bolus for 100 adult patients admitted to the intensive care unit will be included in the study.
Status | Recruiting |
Enrollment | 100 |
Est. completion date | January 2020 |
Est. primary completion date | December 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients admitted to the intensive care unit and prescribed a fluid bolus. Exclusion Criteria: - The intensive care physician declines to participate. - Expected survival < 24h |
Country | Name | City | State |
---|---|---|---|
Australia | Austin Hospital | Melbourne | Victoria |
Sweden | Danderyds sjukhus | Stockholm | Danderyd |
Sweden | Södersjukhuset | Stockholm |
Lead Sponsor | Collaborator |
---|---|
Karolinska Institutet | Austin Hospital, Melbourne Australia, Danderyd Hospital |
Australia, Sweden,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Accuracy of anticipated hemodynamic effects at completion of bolus | The accuracy and precision between the expected and the observed physiological effects will be described using Bland-Altman methodology | At completion of bolus | |
Secondary | Accuracy of anticipated hemodynamic effects at one hour after completion of the fluid bolus | The accuracy and precision between the expected and the observed physiological effects will be described using Bland-Altman methodology | At one hour after completion of the fluid bolus | |
Secondary | The hemodynamic effects of a fluid bolus at completion of bolus | The effect of the fluid bolus on blood pressure at completion of bolus will be described. | At completion of bolus | |
Secondary | The hemodynamic effects of a fluid bolus at one hour after completion of the fluid bolus | The effect of the fluid bolus on blood pressure one hour after completion of the fluid bolus will be described. | At one hour after completion of the fluid bolus | |
Secondary | The hemodynamic effects of a fluid bolus at completion of bolus | The effect of the fluid bolus on heart rate at completion of bolus will be described. | At completion of bolus | |
Secondary | The hemodynamic effects of a fluid bolus at one hour after completion of the fluid bolus | The effect of the fluid bolus on heart rate one hour after completion of the fluid bolus will be described. | At one hour after completion of the fluid bolus | |
Secondary | The hemodynamic effects of a fluid bolus at completion of bolus | The effect of the fluid bolus on cardiac index at completion of bolus will be described. | At completion of bolus | |
Secondary | The hemodynamic effects of a fluid bolus at one hour after completion of the fluid bolus | The effect of the fluid bolus on cardiac index one hour after completion of the fluid bolus will be described. | At one hour after completion of the fluid bolus | |
Secondary | The hemodynamic effects of a fluid bolus at completion of bolus | The effect of the fluid bolus on CVP at completion of bolus will be described. | At completion of bolus | |
Secondary | The hemodynamic effects of a fluid bolus at one hour after completion of the fluid bolus | The effect of the fluid bolus on CVP one hour after completion of the fluid bolus will be described. | At one hour after completion of the fluid bolus | |
Secondary | The hemodynamic effects of a fluid bolus at completion of bolus | The effect of the fluid bolus on ScVO2 or SvO2 at completion of bolus will be described. | At completion of bolus | |
Secondary | The hemodynamic effects of a fluid bolus at one hour after completion of the fluid bolus | The effect of the fluid bolus on ScVO2 or SvO2 one hour after completion of the fluid bolus will be described. | At one hour after completion of the fluid bolus | |
Secondary | The hemodynamic effects of a fluid bolus at completion of bolus | The effect of the fluid bolus on lactate levels at completion of bolus will be described. | At completion of bolus | |
Secondary | The hemodynamic effects of a fluid bolus at one hour after completion of the fluid bolus | The effect of the fluid bolus on lactate levels one hour after completion of the fluid bolus will be described. | At one hour after completion of the fluid bolus | |
Secondary | The hemodynamic effects of a fluid bolus at completion of bolus | The effect of the fluid bolus on urine output at completion of bolus will be described. | At completion of bolus | |
Secondary | The hemodynamic effects of a fluid bolus at one hour after completion of the fluid bolus | The effect of the fluid bolus on urine output one hour after completion of the fluid bolus will be described. | At one hour after completion of the fluid bolus |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05095324 -
The Biomarker Prediction Model of Septic Risk in Infected Patients
|
||
Completed |
NCT02714595 -
Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
|
Phase 3 | |
Completed |
NCT03644030 -
Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
|
||
Completed |
NCT02867267 -
The Efficacy and Safety of Ta1 for Sepsis
|
Phase 3 | |
Completed |
NCT04804306 -
Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
|
||
Recruiting |
NCT05578196 -
Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.
|
N/A | |
Terminated |
NCT04117568 -
The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
|
||
Completed |
NCT03550794 -
Thiamine as a Renal Protective Agent in Septic Shock
|
Phase 2 | |
Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
Completed |
NCT04227652 -
Control of Fever in Septic Patients
|
N/A | |
Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
Recruiting |
NCT04005001 -
Machine Learning Sepsis Alert Notification Using Clinical Data
|
Phase 2 | |
Completed |
NCT03258684 -
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock
|
N/A | |
Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
Completed |
NCT05018546 -
Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery
|
N/A | |
Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
Not yet recruiting |
NCT06045130 -
PUFAs in Preterm Infants
|
||
Not yet recruiting |
NCT05361135 -
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
|
N/A | |
Not yet recruiting |
NCT05443854 -
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
|
Phase 3 |